intellectual property
AGEFI | 13-Apr-2017
Le géant bâlois est accusé d’avoir "menacé" le ministère colombien du Commerce et de l’Industrie de recourir à un tribunal d’arbitrage international.
Public Eye | 12-Apr-2017
Confidential documents obtained by Public Eye show that Novartis has threatened Colombia with international investment arbitration under its BIT with Switzerland to avoid the issuance of a compulsory license
IA Reporter | 5-Apr-2017
Ukraine has settled a dispute with American pharmaceutical company Gilead Sciences Inc., following the company’s pursuit of legal remedies in both domestic courts and via investment arbitration.
Public Citizen | 1-Apr-2017
Novartis battle against Colombian Government highlights the threats to public health posed by the outrageous investor-state dispute settlement regime and bad “trade” deals.
Lexology | 27-Mar-2017
The Tribunal found that Eli Lilly had failed to demonstrate that the promise doctrine constitutes a fundamental or dramatic change in the utility requirement under Canadian patent law or that the promise doctrine is arbitrary and/or discriminatory.
Tech Dirt | 22-Mar-2017
One of the negotiations that has been going on in the background is for a major trade agreement between the EU and Japan since 2013.
Houssenia Writing | 22-Mar-2017
Depuis 2013, l’Union européenne négocie un autre traité de libre-échange appelé JEFTA (Japan-EU Free Trade Agreement) avec le Japon. Les mécanismes d’arbitrage sont au menu.
Tech Dirt | 22-Mar-2017
Just the fact that the Canadian government had to go through this massive and expensive process for many years just for rejecting two bad patents should show why ISDS provisions are such a problem.
Politico | 20-Mar-2017
Canada has prevailed over pharmaceutical giant Eli Lilly in a long-running investor-state dispute the drug company filed under NAFTA’s investment chapter.
Sunday Guardian Live | 27-Feb-2017
There is no principled basis for EU’s demand of extending patent protection beyond the period of 20 years.

0 | 10 | 20 | 30 | 40 | 50 | 60 | 70